<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-11-07</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39506152/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Coordinated inheritance of extrachromosomal DNAs in cancer cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39506152-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The chromosomal theory of inheritance dictates that genes on the same chromosome segregate together while genes on different chromosomes assort independently¹. Extrachromosomal DNAs (ecDNAs) are common in cancer and drive oncogene amplification, dysregulated gene expression and intratumoural heterogeneity through random segregation during cell division^(2,3). Distinct ecDNA sequences, termed ecDNA species, can co-exist to facilitate intermolecular cooperation in cancer cells⁴. How multiple &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39506352/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Mobile stroke units services in Germany: A cost-effectiveness modeling perspective on catchment zones, operating modes, and staffing</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39506352-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Major determinants of cost-effectiveness should be addressed when setting up novel MSU programs. Catchment zones of more than 500,000-700,000 inhabitants and operating times of at least 12-16 h per day, 7 days per week could enable the most cost-effective MSU services in the German healthcare &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39506679/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241107171250&amp;v=2.18.0.post9&#43;e462414">Prediction of antibody-antigen interaction based on backbone aware with invariant point attention</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39506679-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241107171250-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Quantitative experimental results demonstrate that the new neural network architecture significantly outperforms the best sequence-based methods as well as the methods based on residue contact maps and graph convolution networks (GCNs). The source code is freely available on GitHub at <a href="https://github.com/gmthu66/AbAgIPA">https://github.com/gmthu66/AbAgIPA</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39506708/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Lost in translation: the lack of agreement between surgeons and scientists regarding biomaterials research and innovation for treating bone defects</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39506708-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: To conclude, this study was conducted through a web-based survey, highlighting a substantial translational gap. It underscores the immediate need (&ldquo;call to action&rdquo;) for meaningful interdisciplinary collaboration between surgeons and scientists, often referred to as the need to &ldquo;walk the talk&rdquo;. The findings underscore the critical importance of aligning clinical needs, research outcomes, and regulatory frameworks to improve the development and implementation of biomaterial-based &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39506809/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Etrinabdione (VCE-004.8), a B55α activator, promotes angiogenesis and arteriogenesis in critical limb ischemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39506809-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The findings presented in this study indicate that Etrinabdione holds promise in mitigating endothelial cell damage and senescence, while concurrently fostering arteriogenesis and angiogenesis. These observations position Etrinabdione as a compelling candidate for the treatment of PAD, and potentially other cardiovascular &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39506820/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Magnetic resonance imaging-guided single-fraction preoperative radiotherapy for early-stage breast cancer (the RICE trial): feasibility study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39506820-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The RICE trial represents a significant step in breast cancer treatment, offering insights that could lead to treatment protocols with minimized RT appointments and enhanced patient &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39506894/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39506894-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Since 2017, targeted therapies combined with conventional intensive chemotherapy have started to improve outcome of patients with acute myeloid leukemia (AML). However, even before these innovations outcomes with intensive chemotherapy have improved, which has not yet been extensively studied. Thus, we used a large pan-European multicenter dataset of the HARMONY Alliance to evaluate treatment-time dependent outcomes over two decades. In 5359 AML patients, we compared the impact of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39507214/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">New results on optimal conditional error functions for adaptive two-stage designs</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39507214-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Unblinded interim analyses in clinical trials with adaptive designs are gaining increasing popularity. Here, the type I error rate is controlled by defining an appropriate conditional error function. Since various approaches to the selection of the conditional error function exist, the question of an optimal choice arises. In this article, we extend existing work on optimal conditional error functions by two results. Firstly, we prove that techniques from variational calculus can be applied &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39507511/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Comparing Patient&#39;s Confidence in Clinical Capabilities in Urology: Large Language Models Versus Urologists</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39507511-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS AND CLINICAL IMPLICATIONS: Our study demonstrates that urological patients prefer AI as a powerful complement to-rather than a replacement for-human expertise in clinical care. Patients appreciated the additional consultation time provided by AI. Interestingly, age was not associated with confidence in AI, suggesting that large language models are user-friendly tools for patients of all age &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39507516/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">QCD challenges from pp to AA collisions: 4th edition</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39507516-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This paper is a write-up of the ideas that were presented, developed and discussed at the fourth International Workshop on QCD Challenges from pp to AA, which took place in February 2023 in Padua, Italy. The goal of the workshop was to focus on some of the open questions in the field of high-energy heavy-ion physics and to stimulate the formulation of concrete suggestions for making progresses on both the experimental and theoretical sides. The paper gives a brief introduction to each topic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39507681/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">From &#39;strong recommendation&#39; to practice: A pre-test post-test study examining adherence to stroke guidelines for fever, hyperglycaemia, and swallowing (FeSS) management post-stroke</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39507681-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: There is evidence of improved adherence to FeSS Protocols following a &lsquo;strong recommendation&rsquo; for their use in the Australian stroke guidelines. Change in adherence was similar independent of hospital prior participation in a FeSS Intervention study, or stroke unit care. However, maintenance of higher pre-guideline adherence for hospitals prior participation in a FeSS Intervention study suggests that research participation can facilitate greater guideline adherence; and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39507703/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Editorial: Acute and hereditary coagulation disorders</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39507703-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39508111/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Alloplastic Vascular Grafts for Venous Interposition in Pancreatic Surgery: Readily Available and Reliable</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39508111-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Alloplastic venous vascular grafts are safe and readily available tools in pancreatic surgery, especially for long-segmental mesoportal venous &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/11/07/1211165455/the-electoral-college-throwback">The Electoral College (Throwback)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-07</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-11-07-1211165455-the-electoral-college-throwback/">
    
    
    
    
    
      
    
    What is it, why do we have it, and why hasn&rsquo;t it changed? Born from a rushed, fraught, imperfect process, the origins and evolution of the Electoral College might surprise you and make you think differently about not only this upcoming presidential election, but our democracy as a whole.<!-- raw HTML omitted --><!-- raw HTML omitted -->Learn more about sponsor message choices: <!-- raw HTML omitted -->podcastchoices.com/adchoices<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->NPR Privacy &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39501657/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241106184430&amp;v=2.18.0.post9&#43;e462414">Intratumoural programmed cell death protein expression in 92 patients with atypical fibroxanthoma and pleomorphic dermal sarcoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39501657-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241106184430-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39503069/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241106184430&amp;v=2.18.0.post9&#43;e462414">Soft Tissue Undifferentiated Sarcoma Carrying a Novel Onecut1::Nutm1 Fusion</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39503069-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241106184430-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39503375/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241106184430&amp;v=2.18.0.post9&#43;e462414">Can resting lung function predict the response of a person living with motor neuron disease to a hypoxic challenge test?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39503375-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241106184430-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: PlwMND with FVC &gt;2.7L or SpO(2) &gt;97% are unlikely to require oxygen or ventilatory supports for airline travel. A FVC below 2.7L will require a HCT to confidently determine HCT outcome, with testing still required for FVC &lt;1L or baseline SpO(2) &lt;92%, to provide evidence to the airlines for in-flight respiratory &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39503412/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241106184430&amp;v=2.18.0.post9&#43;e462414">Aggression in a Cohort of Male Methamphetamine (METH) Users &lt;em&gt;With&lt;/em&gt; and &lt;em&gt;Without&lt;/em&gt; Kratom (&lt;em&gt;Mitragyna speciosa&lt;/em&gt; Korth.) Use History in Malaysia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39503412-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241106184430-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Methamphetamine (METH) consumption is associated with aggression. Decoction derived from the kratom (Mitragyna speciosa Korth.) leaf has been used as a METH substitute in Southeast Asia. Given its perceived benefit, we investigated the relationship between kratom use and aggression in a treatment sample of METH users with and without kratom use history. Four hundred and three male METH users participated in this cross-sectional study. A semi-structured questionnaire and several &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39503523/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241106184427&amp;v=2.18.0.post9&#43;e462414">siRNADiscovery: a graph neural network for siRNA efficacy prediction via deep RNA sequence analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39503523-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241106184427-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The clinical adoption of small interfering RNAs (siRNAs) has prompted the development of various computational strategies for siRNA design, from traditional data analysis to advanced machine learning techniques. However, previous studies have inadequately considered the full complexity of the siRNA silencing mechanism, neglecting critical elements such as siRNA positioning on mRNA, RNA base-pairing probabilities, and RNA-AGO2 interactions, thereby limiting the insight and accuracy of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39503523/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241107171250&amp;v=2.18.0.post9&#43;e462414">siRNADiscovery: a graph neural network for siRNA efficacy prediction via deep RNA sequence analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39503523-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241107171250-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The clinical adoption of small interfering RNAs (siRNAs) has prompted the development of various computational strategies for siRNA design, from traditional data analysis to advanced machine learning techniques. However, previous studies have inadequately considered the full complexity of the siRNA silencing mechanism, neglecting critical elements such as siRNA positioning on mRNA, RNA base-pairing probabilities, and RNA-AGO2 interactions, thereby limiting the insight and accuracy of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39503590/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241106184430&amp;v=2.18.0.post9&#43;e462414">Eating habits and behaviors in children with Dravet syndrome: A case-control study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39503590-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241106184430-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This study evaluated food preferences and eating behaviors of individuals with Dravet syndrome. Patients diagnosed with Dravet syndrome were recruited, as well as a control group composed of siblings of patients with epilepsy (any form). The Food Preference Questionnaire and the Child Eating Behavior Questionnaire were completed by caregivers along with two open-ended questions regarding eating challenges. Seventy-eight participants (45 with Dravet syndrome and 33 controls) were &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39503712/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241106184430&amp;v=2.18.0.post9&#43;e462414">Investigating Molecular Junctions Based on Mixed Self-Assembled Monolayers to Understand the Impact of Intermolecular Interactions on Transport</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39503712-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241106184430-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    To interrogate the importance of intermolecular interactions on charge transport at the nanoscale, we investigate molecular tunnel junctions based on mixed self-assembled monolayers (SAMs) of 1-alkyl (CnT) thiols and their fluorinated counterparts (F-CnT) that have substantially different tunneling conductances. Experiments on mixed CnT(1-x):F-CnT(x) SAMs between Au contacts reveal a strongly nonlinear (exponential) dependence of the tunneling conductance G on composition x, a behavior that &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39503734/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241106184430&amp;v=2.18.0.post9&#43;e462414">Neural Thermodynamic Integration: Free Energies from Energy-Based Diffusion Models</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39503734-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241106184430-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Thermodynamic integration (TI) offers a rigorous method for estimating free-energy differences by integrating over a sequence of interpolating conformational ensembles. However, TI calculations are computationally expensive and typically limited to coupling a small number of degrees of freedom due to the need to sample numerous intermediate ensembles with sufficient conformational-space overlap. In this work, we propose to perform TI along an alchemical pathway represented by a trainable &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504038/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241106184430&amp;v=2.18.0.post9&#43;e462414">Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin Syndrome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504038-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241106184430-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504410/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241106184430&amp;v=2.18.0.post9&#43;e462414">Oxygen consumption measurements at ultra-high dose rate over a wide LET range</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504410-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241106184430-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The measured consumption rates demonstrate a distinct LETd dependence. The obtained dataset, encompassing a wide range of LETd values, could serve as a benchmark for Monte Carlo simulations, which may aid in enhancing our comprehension of oxygen-related mechanisms after irradiations. Ultimately, they could help assess the viability of different hypotheses regarding UHDR sparing mechanisms and the FLASH effect. The found LETd dependence underscores the potential of heavy ion &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504485/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241106184310&amp;v=2.18.0.post9&#43;e462414">Acute Promyelocytic Leukemia: Long-Term Outcomes from the HARMONY Project</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504485-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241106184310-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our study confirms the superiority of ATRA-ATO over ATRA-chemotherapy in APL patients. ED represents an unmet medical need, in particular in older patients and in high-risk &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504485/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241107171247&amp;v=2.18.0.post9&#43;e462414">Acute Promyelocytic Leukemia: Long-Term Outcomes from the HARMONY Project</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504485-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241107171247-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our study confirms the superiority of ATRA-ATO over ATRA-chemotherapy in APL patients. ED represents an unmet medical need, in particular in older patients and in high-risk &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504497/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241106184430&amp;v=2.18.0.post9&#43;e462414">Meta-connected Oligo-Azobenzenes Outperform Their Para Counterparts</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504497-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241106184430-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Systems with multiple photoswitchable units in one molecule have attracted considerable attention in the past years as they are useful for a broad variety of possible applications. Especially, linked azobenzenes sharing one benzene ring are of high interest since their direct linkage introduces an additional photoswitchable unit at only small increase in molecular weight. In this spirit, linear oligoazobenzenes had been synthesized, though their photochemical properties have only &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504497/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Meta-connected Oligo-Azobenzenes Outperform Their Para Counterparts</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504497-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Systems with multiple photoswitchable units in one molecule have attracted considerable attention in the past years as they are useful for a broad variety of possible applications. Especially, linked azobenzenes sharing one benzene ring are of high interest since their direct linkage introduces an additional photoswitchable unit at only small increase in molecular weight. In this spirit, linear oligoazobenzenes had been synthesized, though their photochemical properties have only &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504520/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">Randomized Trial of Very Early Medication Abortion</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504520-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Medication abortion before confirmed intrauterine pregnancy was noninferior to standard, delayed treatment with respect to complete abortion. (Funded by the Swedish Research Council and others; VEMA EudraCT number, 2018-003675-35; ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504520/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Randomized Trial of Very Early Medication Abortion</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504520-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Medication abortion before confirmed intrauterine pregnancy was noninferior to standard, delayed treatment with respect to complete abortion. (Funded by the Swedish Research Council and others; VEMA EudraCT number, 2018-003675-35; ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504521/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">Uterine Fibroids</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504521-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504521/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Uterine Fibroids</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504521-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504522/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">Epidural Glucocorticoid Injection for Lumbosacral Radicular Pain</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504522-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504522/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Epidural Glucocorticoid Injection for Lumbosacral Radicular Pain</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504522-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504523/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">McCune-Albright Syndrome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504523-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504523/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">McCune-Albright Syndrome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504523-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504524/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">Two Sides to the Story</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504524-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504524/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Two Sides to the Story</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504524-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504525/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">SENIOR-RITA - Is It All about Angiography?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504525-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504525/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">SENIOR-RITA - Is It All about Angiography?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504525-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504526/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">Simple Strategies to Reduce Cardiac Strain in Older Adults in Extreme Heat</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504526-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504526/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Simple Strategies to Reduce Cardiac Strain in Older Adults in Extreme Heat</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504526-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504527/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">Audio Interview: The Marburg Virus Outbreak in Rwanda</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504527-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504527/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Audio Interview: The Marburg Virus Outbreak in Rwanda</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504527-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504528/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">Semaglutide for Chronic Kidney Disease in Type 2 Diabetes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504528-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504528/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Semaglutide for Chronic Kidney Disease in Type 2 Diabetes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504528-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504529/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">Semaglutide for Chronic Kidney Disease in Type 2 Diabetes. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504529-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504529/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Semaglutide for Chronic Kidney Disease in Type 2 Diabetes. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504529-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504530/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">Frailty in Older Adults</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504530-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504530/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Frailty in Older Adults</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504530-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504531/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">Frailty in Older Adults</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504531-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504531/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Frailty in Older Adults</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504531-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504532/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">Frailty in Older Adults</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504532-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504532/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Frailty in Older Adults</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504532-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504533/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">Frailty in Older Adults</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504533-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504533/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Frailty in Older Adults</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504533-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504534/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241106184429&amp;v=2.18.0.post9&#43;e462414">Frailty in Older Adults. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504534-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241106184429-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504534/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Frailty in Older Adults. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504534-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504561/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241106184430&amp;v=2.18.0.post9&#43;e462414">Validation of the Revised 2022 European LeukemiaNet Risk Stratification in Adult Patients with Acute Myeloid Leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504561-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241106184430-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In 2022, the European LeukemiaNet (ELN) risk stratification for patients with AML has been updated. We aimed to validate the prognostic value of the 2022 ELN classification (ELN22) evaluating 1,570 newly diagnosed AML patients (median age, 56 years) treated with cytarabine-based intensive chemotherapy regimens. As compared to the 2017 ELN classification (ELN17), allocating 595 (38%), 413 (26%) and 562 (36%) patients to the favorable, intermediate and adverse risk category, ELN22 risk &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504561/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Validation of the Revised 2022 European LeukemiaNet Risk Stratification in Adult Patients with Acute Myeloid Leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504561-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In 2022, the European LeukemiaNet (ELN) risk stratification for patients with AML has been updated. We aimed to validate the prognostic value of the 2022 ELN classification (ELN22) evaluating 1,570 newly diagnosed AML patients (median age, 56 years) treated with cytarabine-based intensive chemotherapy regimens. As compared to the 2017 ELN classification (ELN17), allocating 595 (38%), 413 (26%) and 562 (36%) patients to the favorable, intermediate and adverse risk category, ELN22 risk &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504588/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241106184430&amp;v=2.18.0.post9&#43;e462414">The Drosophila RNA binding protein Hrp48 binds a specific RNA sequence of the msl-2 mRNA 3&#39; UTR to regulate translation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504588-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241106184430-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Repression of msl-2 mRNA translation is essential for viability of Drosophila melanogaster females to prevent hypertranscription of both X chromosomes. This translational control event is coordinated by the female-specific protein Sex-lethal (Sxl) which recruits the RNA binding proteins Unr and Hrp48 to the 3' untranslated region (UTR) of the msl-2 transcript and represses translation initiation. The mechanism exerted by Hrp48 during translation repression and its interaction with msl-2 are &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39504588/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">The Drosophila RNA binding protein Hrp48 binds a specific RNA sequence of the msl-2 mRNA 3&#39; UTR to regulate translation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39504588-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Repression of msl-2 mRNA translation is essential for viability of Drosophila melanogaster females to prevent hypertranscription of both X chromosomes. This translational control event is coordinated by the female-specific protein Sex-lethal (Sxl) which recruits the RNA binding proteins Unr and Hrp48 to the 3' untranslated region (UTR) of the msl-2 transcript and represses translation initiation. The mechanism exerted by Hrp48 during translation repression and its interaction with msl-2 are &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39505414/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">A Guide to Implementation Science for Phase 3 Clinical Trialists: Designing Trials for Evidence Uptake</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39505414-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The delayed and modest uptake of evidence-based treatments following cardiovascular clinical trials highlights the need for greater attention to implementation early in the development and testing of treatments. However, implementation science is not well understood and is often an afterthought following phase 3 trials. In this review, we describe the goals, frameworks, and methods of implementation science, along with common multilevel barriers and facilitators of implementation. We &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39505569/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Large language models as a diagnostic support tool in neuropathology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39505569-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The WHO guidelines for classifying central nervous system (CNS) tumours are changing considerably with each release. The classification of CNS tumours is uniquely complex among most other solid tumours as it incorporates not just morphology, but also genetic and epigenetic features. Keeping current with these changes across medical fields can be challenging, even for clinical specialists. Large language models (LLMs) have demonstrated their ability to parse and process complex medical text, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39505658/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">Prostate Biopsy: The Transrectal Approach Is Safe</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39505658-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    A targeted transrectal biopsy with antibiotic prophylaxis is an effective alternative for patients who do not have access to transperineal biopsy. Transrectal biopsy remains a safe and straightforward method that should continue to be &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39505849/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20241107171233&amp;v=2.18.0.post9&#43;e462414">Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39505849-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20241107171233-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MBL is a precursor condition to chronic lymphocytic leukemia (CLL), characterized by monoclonal B-cells in blood. Mosaic chromosomal alterations (mCAs) are a form of clonal hematopoiesis that include gains, losses, and copy-neutral loss-of-heterozygosity of large DNA segments. Both MBL and mCAs have been found to increase the risk of CLL and lymphoid malignancies, and the aim of our study was to investigate how mCAs relate to MBL, which is currently unknown. We analyzed genetic, flow &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39505858/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39505858-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Genetic variation at the 19q13.3 KLK locus is linked with prostate cancer susceptibility in men. The non-synonymous KLK3 single nucleotide polymorphism (SNP), rs17632542 (c.536 T &gt; C; Ile163Thr-substitution in PSA) is associated with reduced prostate cancer risk, however, the functional relevance is unknown. Here, we identify that the SNP variant-induced change in PSA biochemical activity mediates prostate cancer pathogenesis. The &lsquo;Thr&rsquo; PSA variant leads to small subcutaneous tumours, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39506038/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241107171252&amp;v=2.18.0.post9&#43;e462414">The USP12/46 deubiquitinases protect integrins from ESCRT-mediated lysosomal degradation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39506038-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241107171252-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The functions of integrins are tightly regulated via multiple mechanisms including trafficking and degradation. Integrins are repeatedly internalized, routed into the endosomal system and either degraded by the lysosome or recycled back to the plasma membrane. The ubiquitin system dictates whether internalized proteins are degraded or recycled. Here, we use a genetic screen and proximity-dependent biotin identification to identify deubiquitinase(s) that control integrin surface levels. We &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OF4zMu6Ii">今后四年绿卡估计一卡难求了～</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-of4zmu6ii/">
    
    
    
    
    
      
    
    今后四年绿卡估计一卡难求了～  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OF6zttXz1">2024年大选的一些感想我在2016和2020年大选后，都写了感想，所以这次也不会例外。2022年中期选举，NYT的Nate Cohn的polling（民调）比较准确，而后他从NYT一个不...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-of6zttxz1/">
    
    
    
    
    
      
    
    2024年大选的一些感想<!-- raw HTML omitted --><!-- raw HTML omitted -->我在2016和2020年大选后，都写了感想，所以这次也不会例外。2022年中期选举，NYT的Nate Cohn的polling（民调）比较准确，而后他从NYT一个不起眼小专栏upshot负责人被提拔成了整个NYT大选负责人，可谓年轻有为。没想到大获成功的他却做了个冒险的决定，聘请了新的年轻pollster（民调专家） - Ruth Igielnik作为NYT 2024年大选polling新负责人。我讲了多次，Ruth Igielnik的方法是显著增加Trump voter weight（R选民比重）。她的方法一年以来招至了广泛质疑，甚至被认为她是R partisan的，但没想到结果显示她的poll非常精确，而且她对非裔和拉丁裔的倒戈poll得尤为准确，所以不得不说她白 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OF3Ns44DJ">🔻马斯克：“如果特朗普获胜，爱泼斯坦的客户名单将会公开。”🔻快兑现诺言。#特朗普正式宣布获胜##美国大选追踪# 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-of3ns44dj/">
    
    
    
    
    
      
    
    🔻马斯克：“如果特朗普获胜，爱泼斯坦的客户名单将会公开。”<!-- raw HTML omitted -->🔻快兑现诺言。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#特朗普正式宣布获胜#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OF3V8DkCF">🔻图1炒作什么“德国军舰连红海都不敢走，绕道非洲好望角，但是就敢走台湾海峡”非常无聊，基本上是顺着敌对势力炒作“海峡自由航行”的概念在走。🔻台湾海...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-of3v8dkcf/">
    
    
    
    
    
      
    
    🔻图1炒作什么“德国军舰连红海都不敢走，绕道非洲好望角，但是就敢走台湾海峡”非常无聊，基本上是顺着敌对势力炒作“海峡自由航行”的概念在走。<!-- raw HTML omitted -->🔻台湾海峡水域除了距离两岸中国领土12海里以内的中国领海外，大部分为中国的专属经济区，根据《联合国海洋法公约》第二部分第三节规定，他国船舶在此有“无害通过权”，即“不损害沿海国的和平、良好秩序或安全”的情况下“连续不停地迅速通过”，且“潜水艇及其他潜水器须在海面上航行并展示其旗帜”，但航空器则无权飞越领海上空。<!-- raw HTML omitted -->🔻《中华人民共和国专属经济区和大陆架法》第11条也规定，“任何国家在遵守国际法和中华人民共和国的法律、法规的前提下，在中华人民共和国的专属经济区享有航行、飞越的自由”。<!-- raw HTML omitted -->🔻台湾海峡内水深大都在60米左右，因此国际航运流量巨大，是东亚连接东南亚的航运 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OF40byUK3">你说的是几百几千个俄国频道中的几个？ - 转发 @水獭一般编-阿怡:&amp;ensp;俄罗斯频道在禁止大家开香槟。</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-of40byuk3/">
    
    
    
    
    
      
    
    你说的是几百几千个俄国频道中的几个？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@水獭一般编-阿怡<!-- raw HTML omitted -->: 俄罗斯频道在禁止大家开香槟。 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OF430ddHl">🔻以色列 14 频道主持人当众喝酒庆祝特朗普在美国获胜，他们认为特朗普会为他们而战。#特朗普正式宣布获胜##美国大选追踪# 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-of430ddhl/">
    
    
    
    
    
      
    
    🔻以色列 14 频道主持人当众喝酒庆祝特朗普在美国获胜，他们认为特朗普会为他们而战。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#特朗普正式宣布获胜#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OF46A0rn5">🔻欧盟外交官告诉 CNN，欧洲对特朗普的胜利并不感到惊讶，不再是美国的“脆弱小妹妹”（fragile little sister）🔻笑死。#特朗普正式宣布获胜##美国大选追踪...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-of46a0rn5/">
    
    
    
    
    
      
    
    🔻欧盟外交官告诉 CNN，欧洲对特朗普的胜利并不感到惊讶，不再是美国的“脆弱小妹妹”（fragile little sister）<!-- raw HTML omitted -->🔻笑死。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#特朗普正式宣布获胜#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%25E">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OF46XuOCq">🔻CNN：“世界各国领导人正在考虑与特朗普会面”。🔻但是你配的这个图合适吗？#特朗普正式宣布获胜##美国大选追踪# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-of46xuocq/">
    
    
    
    
    
      
    
    🔻CNN：“世界各国领导人正在考虑与特朗普会面”。<!-- raw HTML omitted -->🔻但是你配的这个图合适吗？<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#特朗普正式宣布获胜#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%25E">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OF4bt5lm9">“专属经济区”不认识？[哆啦A梦吃惊]转人工//@且闻兮:你们这种大旗党鸵鸟是没任何意义的，台湾海峡，我们的货船可以通过台湾海峡才没几年，也就是几十年前这是...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-of4bt5lm9/">
    
    
    
    
    
      
    
    “专属经济区”不认识？<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->转人工//<!-- raw HTML omitted -->@且闻兮<!-- raw HTML omitted -->:你们这种大旗党鸵鸟是没任何意义的，台湾海峡，我们的货船可以通过台湾海峡才没几年，也就是几十年前这是台湾控制的，人家可没说这是公海海域啊，我们可是有人被抓被判刑了的，那时候有承认是公海嘛？现在到你管控了，就又成公 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OF4lN6nht">🔻现在才想起怪拜登？🔻晚了！🔻夺人家鸟位的时候，一切都已标好了价格。🔻晚安。#特朗普正式宣布获胜##美国大选追踪# [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-of4ln6nht/">
    
    
    
    
    
      
    
    🔻现在才想起怪拜登？<!-- raw HTML omitted -->🔻晚了！<!-- raw HTML omitted -->🔻夺人家鸟位的时候，一切都已标好了价格。<!-- raw HTML omitted -->🔻晚安。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#特朗普正式宣布获胜#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%258">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OF4oMC4dl">🔻美国网民正在问：“Where is Kamala？”🔻她还要干三个月呢。#特朗普正式宣布获胜##美国大选追踪# [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-of4omc4dl/">
    
    
    
    
    
      
    
    🔻美国网民正在问：“Where is Kamala？”<!-- raw HTML omitted -->🔻她还要干三个月呢。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#特朗普正式宣布获胜#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&amp;amp;extparam=%23%E7%BE%8E%E5%9B%BD%E5%A4%A7%E9%80%89%E8%BF%BD%E8%B8%AA%23&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OF4y3DHQ6">它当然说错了，它在这里编造了一个“承认公海”的虚假事实。但是每个人讲的都是“专属经济区”，它竖了个“公海”靶子自己打。不要告诉我你也分不清楚EEZ和公海...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-of4y3dhq6/">
    
    
    
    
    
      
    
    它当然说错了，它在这里编造了一个“承认公海”的虚假事实。但是每个人讲的都是“专属经济区”，它竖了个“公海”靶子自己打。不要告诉我你也分不清楚EEZ和公海？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OF2qFeFyG">榮獲第54回仙台廣告大賞推廣部門金獎👏👏👏 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-of2qfefyg/">
    
    
    
    
    
      
    
    榮獲第54回仙台廣告大賞推廣部門金獎<!-- raw HTML omitted -->👏👏👏 <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OF3mm1MG0">粉嫩保 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里 via.nhk_dramas [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-of3mm1mg0/">
    
    
    
    
    
      
    
    粉嫩保<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.nhk_dramas &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hvcvmcbea5j30k00k0qac.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1hvcvmcbea5j30k00k0qac.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OEXLyFBO9">久保史绪里#shiorigram# 今天也是晚上10:45～（JST）被未来的我暴击！？暴击辉夜姬终于开幕了呢。今晚是第18集。今天是非常棒的一集请一定要看！！有点少见的凛...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oexlyfbo9/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shior &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OEXRvvs6I">久保史绪里 「被未来的我暴击！」EP.17 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oexrvvs6i/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->「被未来的我暴击！」EP.17 <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/20">https://h5.sinaimg.cn/upload/20</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OF08L1y2E">久保史绪里 via.nhk_dosta [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-of08l1y2e/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.nhk_dosta <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OF2fxgeKK">久保史绪里 via.nhk_dramas [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-of2fxgekk/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.nhk_dramas <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hvcrgeprwpj30qo">https://tvax4.sinaimg.cn/large/006z6nxLgy1hvcrgeprwpj30qo</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OF31CwAlq">久保史绪里 via.緒行记 ins [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-of31cwalq/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.緒行记 ins <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hvcuuy1z3vj30u">https://tvax4.sinaimg.cn/large/006z6nxLgy1hvcuuy1z3vj30u</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OF3c5xgzT">久保史绪里 via.nhk_dramas [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-of3c5xgzt/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.nhk_dramas <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hvcvmcqeptj30k0">https://tvax2.sinaimg.cn/large/006z6nxLgy1hvcvmcqeptj30k0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OF3czuBIJ">久保史绪里via. gekicine [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-of3czubij/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via. gekicine <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hvcvo85ippj30xc0m8">https://tvax1.sinaimg.cn/large/006z6nxLgy1hvcvo85ippj30xc0m8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OF3H9ptTj">久保史绪里 via.NOGI46ann&amp;nogizaka46 X [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-of3h9pttj/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.NOGI46ann&amp;nogizaka46 X <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy">https://tvax1.sinaimg.cn/large/006z6nxLgy</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://yufree.cn/cn/2024/11/06/mark-twain/">塞姆·克莱门森故居</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-06</span>
  </div>
  <div class="summary">
    <a href="/post/yufree-cn-cn-2024-11-06-mark-twain/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

